Neoadjuvant therapy
Hormone Receptor Positive HER2-negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple Negative Breast Cancers
Publication: Clin Cancer Res. 2024 Nov 19. doi: 10.1158/1078-0432.CCR-24-1553. Read More
Neoadjuvant therapy
Publication: Clin Cancer Res. 2024 Nov 19. doi: 10.1158/1078-0432.CCR-24-1553. Read More
Cureus, part of Springer Nature Author: Jiang et al.
Read More21st Bossche Mamma Congress 2024, P07 Presenter: O'Shaughnessy et al.
Read MoreElucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer
Read MoreSSO 2024 Author: Solis-Pomales et al.
Read MoreThe Breast 75 (2024) 103726 Presenter: van Olmen et al.
Read MoreJournal of Clinical Oncology, April 9, 2024 Presenter: Rios-Hoyo et al.
Read MoreEBCC 2024, Oral Presentation Presenter: Dr. Caroline Drukker
Read MoreMiami Breast 2024, Poster 36 Authors: Audeh et al.
Read MoreMiami Breast 2024, Poster 29 Authors: Audeh et al.
Read More